RxDoctor Payments DataLook up a doctor →

Patrick Buchanan, MD

Interventional Pain Medicine · Camarillo, CANPI 1275828568

Payments from drug & device makers

$453,006in general payments, 2019–2025

Across 1,589 payments — averaging $285.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$261K
  • Painteq LLC$82K
  • Saluda Medical Americas, Inc.$67K
  • MML US, Inc.$9K
  • Boston Scientific$6K
  • Nevro Corp.$6K
  • plus $23K from 53 others
$9,890in research payments, 2019–2025

Across 18 payments — averaging $549.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Painteq LLC$10K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott348$261,000
Painteq LLC171$81,637
Saluda Medical Americas, Inc.176$66,627
MML US, Inc.17$9,008
Boston Scientific84$6,461
Nevro Corp.88$5,505
Medtronic(2 entities)75$5,413
Biotronik NRO, Inc.71$2,580
AbbVie(2 entities)112$2,265
SPR Therapeutics, Inc19$1,536
Spinal Simplicity, LLC11$1,403
Collegium Pharmaceutical, Inc.51$739
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC39$722
Globus Medical12$661
Teva Pharmaceuticals USA, Inc.42$628
Si-bone, Inc.6$564
Vertiflex, Inc.11$526
Amgen(2 entities)22$485
Nalu Medical, Inc.10$482
Lundbeck LLC22$390
Relievant Medsystems, Inc.9$375
IBSA Pharma Inc.16$371
Arbor Pharmaceuticals, Inc.19$346
Pfizer13$241
Scilex Pharmaceuticals Inc.15$232
Biohaven Pharmaceuticals, Inc.7$200
Tersera Therapeutics LLC7$190
Lilly USA, LLC11$187
EBI, LLC2$186
Novartis11$184
Takeda Pharmaceuticals U.S.A., Inc.16$168
Azurity Pharmaceuticals, Inc.7$143
West Therapeutics Development, LLC8$140
Vertex5$140
GRT US Holding, Inc.5$130
Almatica Pharma LLC6$125
Stimwave Technologies Incorporated1$117
Forte Bio-pharma LLC3$113
Assertio Therapeutics, Inc.5$96
Bioventus LLC4$84
Curonix LLC2$63
Redhill Biopharma Inc.4$62
Zyla Life Sciences, Inc.5$59
Radius Health, Inc.2$49
Highridge Medical LLC1$41
Johnson & Johnson2$37
Biodelivery Sciences International, Inc.2$36
Foundation Fusion Solutions, LLC1$35
Sentynl Therapeutics, Inc.2$30
Tonix Medicines, Inc.2$30
Camber Spine Technologies LLC1$28
Fidia Pharma USA Inc.1$22
Team_makena_llc1$21
Merit Medical Systems Inc1$20
Biohaven Pharmaceutical Holding Company Ltd.1$19
Averitas Pharma Inc.1$16
Daiichi Sankyo Inc.1$14
Trevena, Inc.1$12
Avanos Medical1$12

How this compares

$453,006 in reported general payments places this provider in the 95th percentile of 188 interventional pain medicine providers in California.

See all interventional pain medicine providers in California →

Medicare billing

Part B allowed, 2024
$204,614
Medicare patients
248
Services billed
2,388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Camarillo

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →